CoreCap Advisors, LLC

Position in NVAX — Novavax Inc

CIK 1902501 SOUTHFIELD, MI

Position in NVAX

as of Jun 30, 2026 · filed Jul 6, 2026 Compact

Position Value

$405

+$55 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#250

of 263 holders

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CoreCap Advisors, LLC holds $2,312,000 across 78 Biotechnology names. NVAX ranks #52 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	6,755	$367,539
2	MRNA	Moderna, Inc.	4,595	$321,787
3	ARWR	Arrowhead Pharmaceuticals, Inc.	3,000	$244,530
4	VRTX	Vertex Pharmaceuticals Inc / Ma	442	$219,554
5	REGN	Regeneron Pharmaceuticals, Inc.	315	$196,415
6	MDGL	Madrigal Pharmaceuticals, Inc.	280	$150,346
7	ANIX	Anixa Biosciences Inc	52,020	$145,656
8	LGND	Ligand Pharmaceuticals Inc	428	$135,286

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$405	43	0.0%	Shares	Sole	2026-07-06
2026-03-31	$350	43	0.0%	Shares	Sole	2026-04-07
2025-12-31	$288	43	-69.9%	Shares	Sole	2026-01-13
2025-09-30	$1,239	143	0.0%	Shares	Sole	2025-10-22
2025-06-30	$900	143	0.0%	Shares	Sole	2025-08-14
2025-03-31	$916	143	0.0%	Shares	Sole	2025-05-09
2024-12-31	$1,149	143	0.0%	Shares	Sole	2025-02-14
2024-09-30	$1,806	143	0.0%	Shares	Sole	2024-11-08
2024-03-31	$683	143	0.0%	Shares	Sole	2024-08-08
2022-12-31	$1,470	143	-6.5%	Shares	Sole	2023-02-10
2022-06-30	$7,868	153	-71.5%	Shares	Sole	2022-08-11
2021-12-31	$76,685	536	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.